It is not fully understood the impact that COVID-19 has on psoriasis patients. This case series, co-authored by IPC Councilors Cesar González and Fernando Valenzuela, looks at the characteristics of Latin American patients with psoriasis and confirmed or highly suspected COVID-19.
The spread of COVID-19 in early 2020 brought many concerns and questions about COVID-19 and psoriasis. To help address these concerns dermatologists and researchers created PsoProtect and PsoProtectMe — two global registries aimed at understanding the impact of the pandemic on people with psoriasis. Co-directors of PsoProtect and PsoProtectMe, Catherine Smith and Satveer Mahil, speak about the data collection process and findings from these global registries.
The patient perspective has become even more important in the wake of the pandemic. Here’s how Clinica Dermacross is making it a priority.
This revised statement is based on expert opinion and should be interpreted in the context of local policies and emerging evidence.
